Merck & Co., Inc. (MRK)
123.17
-0.65
(-0.52%)
USD |
NYSE |
Mar 02, 09:56
Merck Research and Development Expense (Annual) : 12.51B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Gilead Sciences, Inc. | 5.688B |
| Johnson & Johnson | 14.83B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Moderna, Inc. | 2.917B |